INTRODUCTION {#sec1}
============

Interleukin 7 (**IL-7**), an important cytokine derived from thymic stromal cells, was first identified as a pre-B cell growth factor (Namen et al., [@bib21]; Goodwin et al., [@bib9]; Namen et al., [@bib22]), which is essential for initiating and maintaining activities of immune and hematopoietic systems (Chazen et al., [@bib3]; Schluns and Lefrançois, [@bib24]). IL-7 is crucial for B cell differentiation, proliferation, maturation, and maintenance (Komschlies et al., [@bib16]; Namen et al., [@bib22]), and can thus facilitate the recovery of B cell number after immunological stresses, such as radiation and immunosuppression (Chazen et al., [@bib3]; Miln and Paige, [@bib19]). Consistently, blocking IL-7 by antibody results in rapid reduction of B cell number in bone marrow and thymus (Grabstein, et al., [@bib10]). In addition to its role in B cells, IL-7 also stimulates T cell development, proliferation, and homeostatic regulation (Hickman et al., [@bib11]; Fry and Mackall, [@bib8]). Due to its potent immunity-stimulating ability, recombinant IL-7 has been widely used in humans to treat a number of disorders with immunosuppressive properties, such as AIDS (Beq et al., [@bib2]; Leone et al., [@bib17]), hepatitis (Hou et al., [@bib12]), and cancer (Sportès et al., [@bib27]). In line with this notion, it was shown that recombinant human IL-7 significantly increases CD4^+^ and CD8^+^ cell proliferation in HIV-infected patients (Ferrari et al., [@bib7]; Levy et al., [@bib18]). Although mammalian IL-7 can promote lymphocyte proliferation and maturation, it remains elusive whether poultry IL-7 possesses the similar biological functions as its homologs in mammals.

Infectious bursal disease (**IBD**) is one of the most serious infectious diseases caused by infectious bursal disease virus (**IBDV**) (Müller et al., [@bib20]) in the poultry industry. IBDV attacks the chicken immune system by destroying B and T cells, leading to lymphocyte decline and subsequent systemic immune dysfunction (Sharma et al., [@bib26]). The failure of maintaining lymphocyte numbers and populations in IBDV-infected chicken increases the infection susceptibility to other pathogens, resulting in chicken death due to secondary infection (Ingrao et al., [@bib14]). So far, no effective treatment is available to control this disease. Given that mammalian IL-7 has strong immunoactivating properties, we hypothesized that poultry IL-7 is able to antagonize IBDV-induced immunosuppression and thus possess anti-IBDV activity. In this study, we amplified chicken IL-7 gene, prepared recombinant chIL-7, evaluated its anti-IBDV activity in vivo and investigated the molecular mechanism involved.

MATERIALS AND METHODS {#sec2}
=====================

Cells, Viruses and Chickens {#sec2-1}
---------------------------

Human embryonic kidney (**HEK**) 293T cells were purchased from the Cell Culture Center of Peking Union Medical University (Beijing, China). Mouse immature B lymphocytes (2E8 cells) and UMNSAH/DF-1 chicken embryonic fibroblast cells (DF-1 cells) were purchased from ATCC (Manassas, VA). The virulent IBDV strain HB-1 serotype-1 were kindly presented by Dr. Weiquan Liu in China Agricultural University. Specific pathogen--free (**SPF**) chickens (21-day-old White Leghorn layers) were purchased from a local chicken farm. The chickens were kept in the specific isolator in an environmentally controlled room with a 12/12 hour light/dark cycle. Animal experiments were performed based on the Guide for the Care and Use of Laboratory Animals of the Agricultural University of Hebei.

ChIL-7 Gene Amplification and Vector Construction {#sec2-2}
-------------------------------------------------

Chicken IL-7 gene was amplified by reverse transcription polymerase chain reaction (**RT-PCR**) from chicken spleen with following primers (AM931037). Forward: 5′CGG[GGTACC(]{.ul}*Kpn*[I)]{.ul}ACCATGTCCCCATGCCTTTTTTAGATC and reverse: 5′CCC[GCTCGAG(]{.ul}*Xho*[I)]{.ul}ACACCTTGAAATTATTTTTTCAAATTTATTC. The PCR cycling conditions: initial denaturation at 94°C for 5 min, followed by 30 cycles of denaturation at 94°C for 1 min, annealing at 58°C for 1 min, extension at 72°C for 1.5 min, followed by final extension at 72°C for 10 min. The amplified PCR product was cloned into a T-vector pMD19-T(TaKaRa) and then transferred into pcDNA3.1A plasmid to construct Myc/His-tag-fused chIL-7 gene eukaryotic expression vector, pcDNA-chIL-7/MH.

Expression and Purification of Recombinant chIL-7 {#sec2-3}
-------------------------------------------------

HEK293T cell transfection, recombinant chIL-7 expression and purification with Ni-NTA agarose beads were performed as previously described (Wen et al., [@bib31]). Briefly, the pcDNA-chIL-7/MH plasmids were transfected into HEK293T cells for transient expression mediated by calcium phosphate method. After expression for 48 h in the expression medium (100 μg/mL of BSA and 176 μg/mL butyric acid in Dulbecco\'s modified Eagle\'s medium \[**DMEM**\]), the expressed chIL-7 was absorbed with Ni-NTA agarose beads. After washing with the wash buffer (20 mM Tris, 500 mM NaCl, 10 mM imidazole, pH 8.0). Bound chIL-7 was eluted with elution buffer (20 mM Tris, 500 mM NaCl, 250 mM imidazole, pH 8.0). The eluted chIL-7 was dialyzed against PBS (pH 8.0) to eliminate the imidazole.

Western Blot {#sec2-4}
------------

The recombinant chIL-7 in the culture medium was detected with Western blot as previously described (Wen et al., [@bib31]) using Anti-Myc mAb (Santa Cruz Biotechnologies). For the intracellular chIL-7 detection, the transfected cells were lysed with lysis buffer (5 mM Tris-HCl, 25 mM KCl, 2 mM EGTA, 2 mM EDTA, 1% NP-40, 150 mM NaCl and protease inhibitors) and then subjected to Western blot described as above.

Identification of chIL-7 Bioactivity {#sec2-5}
------------------------------------

The bioactivity of recombinant chIL-7 was determined using mouse immature B lymphocyte 2E8, an IL-7-dependent proliferation-cell line (Van der Spek et al., [@bib29]). The cells were cultured in RPMI-1640 complete medium at 37°C and 5% CO~2~ in-air atmosphere. The cells were seeded into 96-well flat-bottomed plate at the density of 3×10^4^ cells/well with 100 μL of VIVO-15 serum-free medium. Different doses (30, 60, 90, 120, 150 pg/mL) of human IL-7 as positive controls and chIL-7 were individually incubated with the 2E8 cells for 48 h at 37°C. The cell proliferation index (**PI**) was measured using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (**MTT**) method and the chIL-7 bioactivity was evaluated based on the PI values.

Lymphocyte Proliferation Assay {#sec2-6}
------------------------------

Mouse 2E8 cells, or the splenic and bursal lymphocytes isolated from different treated chickens (IBDV-infected, chIL-7-treated IBDV-infected, and uninfected chickens) were stimulated with chIL-7 (0, 0.1, 0.2, 0.5 μg/mL) or concanavalin A (Con A, 100 ng/mL) for 48 h in a 96-well plate. Lymphocyte proliferation was measured by MTT method.

Enzyme-Linked Immunosorbent Assay (ELISA) {#sec2-7}
-----------------------------------------

Chicken interferon-γ (**IFN-γ**) and transforming growth factor-β (**TGF-β**) in the cell culture supernatants were measured by enzyme-linked immunosorbent assay (**ELISA**) using Chicken IFN-γ ELISA kit (HENGFEI, China) and Chicken TGF-β ELISA kit (FKBIO, China), following the manufacture\'s instructions.

Real-time PCR {#sec2-8}
-------------

Chicken IFN-γ and TGF-β mRNA expressions in chicken splenic tissues were measured by qRT-PCR. Total RNA was purified using Trizol reagent (Invitrogen) from splenic tissues. The cDNA was prepared using the iScript cDNA Synthesis Kit (Bio-Rad). Real-time PCR was performed using iQ SYBR Green Supermix (Bio-Rad) with the iCycler iQ RT-PCR detection system (Bio-Rad), with 40 cycles of real-time data collection at 95°C for 30 s, 50°C (IFN-γ) or 62°C (TGF-β) for 1 min and 72°C for 1 min, followed by melt-curve analysis to verify the presence of a single product, using the designed primers, IFN-γ (GenBank: GQ421600): sense 5′CTGCAGGTAGTCTAAATCTTGTTC, antisense 5′TGTCCAGTTCTTCAGTTTCTCT AC; TGF-β (GenBank: JQ423909): sense 5′GGAGGCGGCCAAAAAGAAAC, antisense 5′CCAATACTCATCGGGTCCATCC.

Virus Propagation and Titer Determination {#sec2-9}
-----------------------------------------

IBDV were propagated in DF-1 chicken embryonic fibroblast cells as previously described by Kibenge et al. ([@bib15]). Briefly, DF-1 cells were grown in DMEM complete medium at 37°C in a 5% CO~2~ in-air atmosphere and infected with the pathogenic IBDV strain when the cell density reached 80 to 90% confluence. The cells were harvested at 96 h post infection, the IBDV were released from the cells through more than 3 freeze-thaw cycles and purified using the modified method of Dobos (Dobos et al., [@bib5]). Virus titers were determined by Reed-Muench method and expressed as the 50% tissue culture infective dose (**TCID~50~**).

Animal Experiments {#sec2-10}
------------------

A total of 192 SPF white Leghorn layers (21-day-old) were randomly divided into 8 groups of 24 birds each. Chickens in group 1 and 5, as the controls, were pre-treated with bovine serum albumin (**BSA**) at 2.5 mg/kg/day for 12 d. Chickens in groups 2, 3, and 4, and groups 6, 7, and 8 were pre-treated with chIL-7 at 1, 2.5, and 5 mg/kg/d for 12 d, respectively. All of the chickens were challenged by intramuscular injection with virulent IBDV (0.1 mL of 5 × 10^6^ TCID~50~) at 3 d after chIL-7 (or BSA) treatment. Chickens in groups 1 to 4 were kept for clinical and mortality observation. IBDV titers in the chicken bursal tissue in groups 5 to 8 at the different time (0, 2, 4, 6, 8 d) post infection were measured with TCID~50~. The lymphocyte proliferation, IFN-γ, and TGF-β productions in splenic and bursal tissues at 8 d post infection were analyzed by MTT and ELISA, respectively.

Chicken Splenic and Bursal Lymphocyte Isolation and Culture {#sec2-11}
-----------------------------------------------------------

Chicken splenic and bursal lymphocyte isolation was performed as previously described with slight modifications (Compton and Wickliffe, [@bib4]). Briefly, splenic or bursal tissue was aseptically removed from the chicken and minced into small pieces in RPMI-1640 with sterilized scissors. The pieces were crushed through a cell sieve with a plunger. The homogenate was filtered through 100-μm nylon mesh and washed twice with PBS. The lymphocytes were separated by density gradient centrifugation over Ficoll-Hypaque and washed twice with RPMI-1640, and cultured in RPMI-1640 complete medium in a humidified atmosphere of 5% CO~2~ at 37°C.

Statistics {#sec2-12}
----------

The significance of differences between experimental groups was evaluated by one-way analysis of variance (ANOVA) with Dunnett\'s post-comparison test for multiple groups and Student\'s *t*-test was used for a single comparison of the 2 groups, respectively. All experiments were performed at least 3 times.

RESULTS {#sec3}
=======

Chicken IL-7 Gene Amplification, Sequence Analysis and Expression Vector Construction {#sec3-1}
-------------------------------------------------------------------------------------

We amplified *chIL-7* gene (568 bp) from chicken spleen by RT-PCR (Figure [1A](#fig1){ref-type="fig"}) and then cloned it into the pMD19-T vector. The sequencing results showed that the cloned *chIL-7* gene was consistent with the sequence in GenBank except for one base substitution (A~171~→G~171~), which, however, did not alter encoded amino acid (Figure [1B](#fig1){ref-type="fig"}). By comparison with other species, we found that chIL-7 amino acid sequences showed high homology with other avian species, about 60 - 99% (Table [1](#tbl1){ref-type="table"}), but low homology with non-avian species (about 30%) (Table [1](#tbl1){ref-type="table"}). chIL-7 gene in pMD19-T vector was transferred into pcDNA3.1A plasmid to construct Myc/His-tag-fused chIL-7 eukaryotic expression vector, pcDNA-chIL7/MH (Figure [1C](#fig1){ref-type="fig"}). The restriction analysis showed that the expression vector was correct (Figure [1D](#fig1){ref-type="fig"}).

![ChIL-7 gene amplification and its eukaryotic expression vector construction. (A) Chicken IL-7 cDNA gene amplified by RT-PCR: Lane 1, IL-7 gene PCR product; M, DL2000™ DNA marker. (B) The gene sequence of chicken IL-7 and its encoded amino acids: The italic letters present the signal peptide. (C) Eukaryotic expression vector of chIL-7 gene driven by CMV promoter. (D) Restriction analysis for the chIL-7 expression vector: Lane 1, *Xho* I and *Kpn* I double digestion; Lane 2, chIL-7 expression vector; M, DL2000™ DNA marker.](pew251fig1){#fig1}

###### 

Homology of chIL-7 with non-avian and avian species.

  Species             GenBank No.    Homology (%)
  ------------------- -------------- --------------
  Non-avian animals                  
  Human               J04156.1       30
  Mouse               NM_008371      32
  Ovine               NM_173924      31
  Porcine             NM_214135      31
  Avian animals                      
  Chicken             AM931037       99.8
  Cristata            XM_009703214   98
  Apteryx             LK064683       72

Recombinant chIL-7 Can Be Expressed in a Secretory Manner in HEK293T Cells. {#sec3-2}
---------------------------------------------------------------------------

To test whether pcDNA-chIL7/MH vector can mediate chIL-7 secretory expression, we used HEK293T cells to express chIL-7, purified with Ni-NTA Agarose beads and identified with Western blot. As shown in Figure [2A](#fig2){ref-type="fig"} and [2B](#fig2){ref-type="fig"}, the specific hybridized band (about 25 kDa) were detected in the culture supernatant from pcDNA-chIL7/MH-transfected cells, but not from pcDNA3.1A empty vector-transfected cells, indicating that the chIL-7 vector could mediate chIL-7 expression in eukaryotic cells in a secretory manner. The size of the recombinant chIL-7 was bigger than that of the calculated molecular weight (18 kDa) based on amino acids, suggesting the chIL-7 might be a glycosylated protein since 4 potential N-glycosylated sites exist in chIL-7 sequence. To check intracellular recombinant chIL-7 in the HEK293T cells, the transfected cells were lysed with cell lysis buffer and subjected to Western blot. Results in Figure [2A](#fig2){ref-type="fig"} showed that the recombinant chIL-7 with the similar size were detected both in cell lysate and culture medium (Figure [2C](#fig2){ref-type="fig"}).

![Detection of the recombinant chicken IL-7 by Western Blot. (A) Detection of chIL-7 in the culture medium from pcDNA-chIL7/MH vector-transfected cells (Lane 1) and pcDNA3.1A empty vector-transfected cells (Lane 2); M, prestained protein markers. (B) Purified chIL-7 proteins eluted from Ni-NTA Agarose column: M, prestained protein markers; Lanes 1--4, elutes 1--4 of chIL-7. (C) Detection of chIL-7 from the cell lysate (Lane 1) and the culture medium (Lane 2); M, prestained protein markers.](pew251fig2){#fig2}

Recombinant chIL-7 Promotes Lymphocyte Proliferation {#sec3-3}
----------------------------------------------------

To determine whether the recombinant chIL-7 possesses bioactivity, we took advantage of the MTT method to measure proliferation of mouse immature B lymphocyte 2E8 with or without chIL-7 treatment. Results showed that the chIL-7 dose-dependently increased 2E8 B lymphocyte stimulation index (Figure [3](#fig3){ref-type="fig"}), indicating that recombinant chIL-7 is biologically active.

![The stimulation index of chIL-7 on 2E8 cells at different doses measured by MTT.](pew251fig3){#fig3}

ChIL-7 Promotes Chicken Immunity Against IBDV {#sec3-4}
---------------------------------------------

To investigate the anti-IBDV immunity of recombinant chIL-7 in vivo, we pre-treated chickens with different doses of chIL-7 for 12 d, followed by IBDV infection at 3 d after chIL-7 treatment. IBDV titers in the bursal tissue under the different doses of IL-7 treatment at the different time were measured. The mortality of the infected chickens was calculated at 2, 4, 6, 8 d after IBDV infection. Results showed that chIL-7 dose-dependently reduced IBDV titers in the bursal tissues during the tested periods compared with that of untreated chickens (Figure [4A](#fig4){ref-type="fig"}), suggesting that chIL-7 could inhibit IBDV replication in vivo. Moreover, chIL-7 also drastically reduced the mortalities of the IBDV-infected chickens (Figure [4B](#fig4){ref-type="fig"}), suggesting the therapeutic potential of chIL-7 against IBDV.

![The effects of chIL-7 on IBDV titers in bursal tissues and survival of IBDV-infected chicken. **(A)** The effects of chIL-7 on IBDV titers in bursal tissues of IBDV-infected chicken. (B) The effects of chIL-7 at different doses (1, 2.5, and 5 mg/kg/d) on the mortality of IBDV-infected chicken. The experimental data are presented as means ± standard deviation.](pew251fig4){#fig4}

ChIL-7 Stimulates Chicken Lymphocyte Proliferation and IFN-γ Production {#sec3-5}
-----------------------------------------------------------------------

To investigate the effects of chIL-7 on lymphocyte proliferation and IFN-γ production, the bursal and splenic lymphocytes were isolated from the untreated chickens and stimulated with different doses of chIL-7 for 48 h*.* As shown in Figure [5A and B](#fig5){ref-type="fig"}, chIL-7 induced proliferation of bursal and splenic lymphocyte in a dose-dependent manner. To further confirm this ex vivo, the isolated splenic lymphocytes from chIL-7-treated IBDV-infected chickens were stimulated with Con A (100 ng/mL) for 48 h. Consistent with the in vitro results, chIL-7 also promoted lymphocyte proliferation of IBDV-infected chickens (Figure [5C](#fig5){ref-type="fig"}).

![The effects of chIL-7 on lymphocyte proliferation and INF-γ production. Effects of chIL-7 on bursal (A) and splenic (B) lymphocyte proliferations isolated from IBDV-uninfected chicken measured by MTT. (C) Effects of chIL-7 on splenic lymphocyte proliferation isolated from IBDV-infected chicken, stimulated with Con A for 48 h, measured by MTT. (D) Effects of chIL-7 on INF-γ productions in the culture medium of the splenic lymphocytes isolated from IBDV-uninfected chicken measured by ELISA. (E) Effects of chIL-7 on INF-γ mRNA expression in splenic tissues of IBDV-infected chicken measured by real-time PCR. The experimental data are presented as means ± standard deviation. \* *P* \< 0.05; \*\* *P* \< 0.01.](pew251fig5){#fig5}

To test whether chIL-7 can stimulate IFN-γ production from chicken lymphocytes in vitro, we treated splenic lymphocytes from naive chickens with chIL-7 and found that chIL-7 dose-dependently promoted IFN-γ production (Figure [5D](#fig5){ref-type="fig"}). To confirm this in vivo, we analyzed the IFN-γ production in the chicken splenic tissues at 8 d after IBDV infection with Real-time PCR and showed that chIL-7 also stimulated IFN-γ production in the splenic tissues in a dose-dependent manner (Figure [5E](#fig5){ref-type="fig"}). These results collectively suggest that chIL-7 stimulates chicken lymphocyte proliferation and IFN-γ production, which might contribute to its anti-IBDV ability in chickens.

Chicken IL-7 Suppresses Chicken TGF-β Expression {#sec3-6}
------------------------------------------------

TGF-β is a potent immunosuppressive cytokine regulating immune homostasis (Akhurst and Hata, [@bib1]). Previous report showed that IBDV could stimulate TGF-β expression in chicken lymphoid tissues, which was thought to promote IBDV-induced immunosuppression in chickens (Sharma et al., [@bib25]; Eldaghayes et al., [@bib6]). We reasoned that chIL-7 might inhibit IBDV-induced TGF-β expression, resulting in enhancement of antiviral activity against IBDV. To test this, we treated splenic lymphocytes from naive chickens with chIL-7 and analyzed TGF-β concentration in the culture supernatant by ELISA. Meanwhile, we analyzed TGF-β mRNA levels in splenic tissues of chIL-7-treated IBDV-infected chickens 8 d post infection by real-time PCR. Consistent with ELISA results, chIL-7 significantly inhibited TGF-β expression in splenic lymphocytes in a dose-dependent manner in vitro (Figure [6A](#fig6){ref-type="fig"}), and also inhibited TGF-β expression in splenic tissues of IBDV-infected chickens ex vivo (Figure [6B](#fig6){ref-type="fig"}). These results indicate that chIL-7 might possess the capacity to inhibit TGF-β--mediated immunosuppression, which promotes its anti-IBDV immunity in chickens.

![The effects of chIL-7 on chicken TGF-β expression in vitro and in vivo. (A) Effects of chIL-7 on TGF-β expression of splenic lymphocytes isolated from IBDV-uninfected chicken measured by ELISA. (B) Effects of chIL-7 on TGF-β mRNA levels in splenic tissues of IBDV-infected chicken for 8 d measured by real-time PCR. The experimental data are presented as means ± standard deviation. \* *P* \< 0.05; \*\* *P* \< 0.01.](pew251fig6){#fig6}

DISCUSSION {#sec4}
==========

In this study, we cloned chIL-7 cDNA gene, prepared recombinant chIL-7 using HEK293T eukaryotic cell line, analyzed its regulatory functions on splenic lymphocyte proliferation and IFN-γ production, and evaluated its antiviral activity against IBDV in vivo. Our results indicated that, like non-avian species, chIL-7 has the ability to stimulate lymphocyte (2E8 B cells) proliferation and also suggested that the mouse 2E8 B cells can be used to evaluate chIL-7 biological activity since the mouse 2E8 B cells have been extensively used to test human and mouse IL-7 biological activity (van der Spek et al., [@bib29]). The HEK293T cell, a eukaryotic cell line, was identified to be a suitable expression cell line for recombinant chIL-7 preparation. We initially used *E. coli* expression system to prepare the chIL-7, but found that its biological activity was very low (data not shown), probably due to the lack of post-translation modification in the *E. coli* system.

We found that chIL-7 could stimulate mouse 2E8 B cells and chicken bursal and splenic lymphocyte proliferation and IFN-γ production, suggesting that chIL-7, a multifunctional cytokine, has the capacity to promote B and T cell-mediated immune responses, which might contribute to the chicken immune restoration from immunosuppression.

IBD is a viral immunosuppressive disease caused by IBDV. The IBDV not only destroys B cell population (Hulse and Romero, [@bib13]), but also attacks T cells by inducing T cell-mediated cellular immunosuppression (Yeh et al., [@bib32]; Ingrao et al., [@bib14]; Wang et al., [@bib30]). Therefore, to stimulate and restore B and T cell-mediated immune responses in IBDV-induced immunosuppression in chicken is critical for IBD prevention and treatment (Rautenschlein et al., [@bib23]). Coincidentally, chIL-7 could promote B and T cell immune responses by stimulating their proliferation and IFN-γ production, which presumably promotes its antiviral activity against IBDV in vivo. Furthermore, chIL-7 also inhibits TGF-β expression, which at least partially explains the immunity-promoting effect of chIL-7. Similar to human IL-7, chIL-7 is capable of promoting host immunity and antagonizing immune suppression by stimulating lymphocyte proliferation and IFN-γ production, and retarding inhibitory cytokine expression. Moreover, as IBDV-induced TGF-β expression in chicken lymphoid organs is crucial for IBDV-induced immunosuppression, the chIL-7-mediated inhibition of TGF-β expression should help to restore chicken antiviral immunity against IBDV. Together, these results suggest that chIL-7 might be a potential therapeutic agent for certain virus-induced immunosuppression diseases in chickens.
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